CAS 511-09-1
:Ergocriptina
- (2'Xi,12'Xi)-12'-Hydroxy-5'-(2-Methylpropyl)-3',6',18-Trioxo-2'-(Propan-2-Yl)Ergotaman
- (5'Alpha)-12'-Hydroxy-5'-(2-Methylpropyl)-3',6',18-Trioxo-2'-(Propan-2-Yl)Ergotaman
- (5′α)-12′-Hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)ergotaman-3′,6′,18-trione
- 12'-Hydroxy-5'-(2-Methylpropyl)-3',6',18-Trioxo-2'-(Propan-2-Yl)Ergotaman
- 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3′,6′,18-trione deriv.
- ALPHA-Ergocryptine
- Ergocryptine
- Ergokryptine
- Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)-, (5′α)-
- Indolo[4,3-fg]quinoline, ergotaman-3′,6′,18-trione deriv.
- NSC 169479
- NSC 407319
- Vedi altri sinonimi
Bromocriptine EP Impurity B
CAS:Formula:C32H41N5O5Colore e forma:Off-White SolidPeso molecolare:575.71α-Ergocryptine
CAS:Stability Hygroscopic
Applications α-Ergocryptine is an ergopeptine and one of the ergot alkaloids. An impurity of 2-Bromo α-Ergocryptine Mesylate (B682600).
References Young, J., et al.: J. Environ. Sci. Health, 16, 83 (1981), Sugrue, M., et al.: J. Med. Chem., 40, 2793 (1997),Formula:C32H41N5O5Colore e forma:NeatPeso molecolare:575.7Ref: ST-EA-CP-B83015
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaRef: ST-EA-CP-B83009
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaa-Ergocryptine
CAS:Prodotto controllatoa-Ergocryptine is an ergot alkaloid derivative, which is a compound sourced from the ergot fungus, particularly *Claviceps purpurea*. Its mode of action involves dopaminergic activity, primarily acting as a dopamine receptor agonist. By binding to dopamine receptors, a-Ergocryptine influences neurotransmitter pathways that regulate various physiological functions.Utilized predominantly in the field of neurology and endocrinology, a-Ergocryptine's applications include the treatment of Parkinson's disease, where it aids in managing symptoms by compensating for dopamine deficiencies. Additionally, it is employed in the control of hyperprolactinemia, effectively reducing elevated prolactin levels, and is sometimes used in addressing menstrual disorders linked to prolactin. Its ability to modulate prolactin and dopamine levels makes it a valuable tool in specific therapeutic protocols. However, its use requires careful medical supervision due to potential side effects and interactions with other medications, emphasizing the need for targeted application within clinical practice.
Formula:C32H41N5O5Purezza:Min. 95%Peso molecolare:575.7 g/mol




